Ryan D. Maynard
2009
In 2009, Ryan D. Maynard earned a total compensation of $1.2M as Executive Vice President, Chief Financial Officer at Rigel Pharmaceuticals, a 32% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $168,000 |
|---|---|
| Option Awards | $703,170 |
| Salary | $300,000 |
| Other | $540 |
| Total | $1,171,710 |
Maynard received $703.2K in option awards, accounting for 60% of the total pay in 2009.
Maynard also received $168K in non-equity incentive plan, $300K in salary and $540 in other compensation.
Rankings
In 2009, Ryan D. Maynard's compensation ranked 3,919th out of 9,885 executives tracked by ExecPay. In other words, Maynard earned more than 60.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,919 out of 9,885 | 60th |
Division Manufacturing | 1,392 out of 3,690 | 62nd |
Major group Chemicals And Allied Products | 265 out of 871 | 70th |
Industry group Drugs | 155 out of 643 | 76th |
Industry Pharmaceutical Preparations | 121 out of 446 | 73rd |
Source: SEC filing on April 12, 2012.
Maynard's colleagues
We found four more compensation records of executives who worked with Ryan D. Maynard at Rigel Pharmaceuticals in 2009.
2009
James Gower
Rigel Pharmaceuticals
Chief Executive Officer
2009
Donald Payan
Rigel Pharmaceuticals
Executive Vice President, President of Discovery and Research
2009
Raul Rodriguez
Rigel Pharmaceuticals
Chief Operating Officer
2009
Elliott Grossbard
Rigel Pharmaceuticals